GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N95023F00001CURIA GLOBAL INC

Overview

Award facts

Net obligations
$907.79K
$907,792of $907.79K potential value
Outlays (paid to date)
$859.31K
$859.31K paid of $907.79K obligated$859,313
Period of performance
Sep 30, 2023 to Apr 30, 2028
Ends in 17 months
Modifications
2
Latest action Dec 20, 2024
Contract type
Delivery order
PIID 75N95023F00001

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL

Dates and value

Award date
Signed on Sep 27, 2023
Potential end of performance
Apr 29, 2028
Current value
$907,792Base and exercised options
Potential value (if all options are exercised)
$907,792
Parent contract vehicle
HHSN271201700005I (IDC, multiple award) — 4 orders recorded under it

Obligations by fiscal year of action

  • FY2025: $82,604
  • FY2024: $280,124
  • FY2023: $545,063

Total across 3 fiscal years: $907,792

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 20, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationALBANY, NY
UEIELCNZCS8GEA3
CAGE code3D1R9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NCATS
Funded from
National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)

Place of performance

Place of performance
Albany, New York 12203-5154
Congressional district (place of performance)
NY-20As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Firm fixed priceJ
Offers received
2

Solicitation and notices

Solicitation ID
75N95023R00059(as reported)
Solicitation date
Jul 12, 2023

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Cro support for ncats drug substance development and manufacture
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 27, 2023Base obligation at award: $545,063
Latest action
Dec 20, 2024 — Option exercisedModification P00002; obligation change +$82,604
Latest substantive action
Dec 20, 2024 — Option exercisedModification P00002; obligation change +$82,604
Actions by type
  • Base award1
  • Option exercised2
3 actions recorded, Sep 27, 2023 to Dec 20, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$82,604

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N95C
Treasury accounts
  • 075-2023/2023-0875-000
  • 075-2024/2024-0875-000
  • 075-2025/2025-0875-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression